These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8662911)
1. Characterization of lactogen receptor-binding site 1 of human prolactin. Kinet S; Goffin V; Mainfroid V; Martial JA J Biol Chem; 1996 Jun; 271(24):14353-60. PubMed ID: 8662911 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a second receptor binding site on human prolactin. Goffin V; Struman I; Mainfroid V; Kinet S; Martial JA J Biol Chem; 1994 Dec; 269(51):32598-606. PubMed ID: 7798264 [TBL] [Abstract][Full Text] [Related]
3. Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity. Goffin V; Norman M; Martial JA Mol Endocrinol; 1992 Sep; 6(9):1381-92. PubMed ID: 1435787 [TBL] [Abstract][Full Text] [Related]
4. The addition of nine residues at the C-terminus of human prolactin drastically alters its biological properties. Goffin V; Struman I; Goormaghtigh E; Martial JA Eur J Biochem; 1993 Jun; 214(2):483-90. PubMed ID: 8513798 [TBL] [Abstract][Full Text] [Related]
5. Amino acids in highly conserved regions near the C-terminus of rat prolactin (PRL) play critical roles similar to those in binding of human GH to the PRL receptor. Kato Y; Maruyama O; Chung HO; Tomizawa K; Kato T Biochem Biophys Res Commun; 1996 May; 222(2):547-52. PubMed ID: 8670242 [TBL] [Abstract][Full Text] [Related]
6. Use of a model to understand prolactin and growth hormone specificities. Goffin V; Martial JA; Summers NL Protein Eng; 1995 Dec; 8(12):1215-31. PubMed ID: 8869634 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2. Broutin I; Jomain JB; Tallet E; van Agthoven J; Raynal B; Hoos S; Kragelund BB; Kelly PA; Ducruix A; England P; Goffin V J Biol Chem; 2010 Mar; 285(11):8422-33. PubMed ID: 20053995 [TBL] [Abstract][Full Text] [Related]
8. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists. Langenheim JF; Tan D; Walker AM; Chen WY Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515 [TBL] [Abstract][Full Text] [Related]
9. Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL. Jomain JB; Tallet E; Broutin I; Hoos S; van Agthoven J; Ducruix A; Kelly PA; Kragelund BB; England P; Goffin V J Biol Chem; 2007 Nov; 282(45):33118-31. PubMed ID: 17785459 [TBL] [Abstract][Full Text] [Related]
10. Different elements of mini-helix 1 are required for human growth hormone or prolactin action via the prolactin receptor. Peterson FC; Brooks CL Protein Eng Des Sel; 2004 May; 17(5):417-24. PubMed ID: 15252206 [TBL] [Abstract][Full Text] [Related]
11. Mechanism for ordered receptor binding by human prolactin. Sivaprasad U; Canfield JM; Brooks CL Biochemistry; 2004 Nov; 43(43):13755-65. PubMed ID: 15504038 [TBL] [Abstract][Full Text] [Related]
12. Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. Goffin V; Kinet S; Ferrag F; Binart N; Martial JA; Kelly PA J Biol Chem; 1996 Jul; 271(28):16573-9. PubMed ID: 8663214 [TBL] [Abstract][Full Text] [Related]
13. Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites. Kinet S; Bernichtein S; Kelly PA; Martial JA; Goffin V J Biol Chem; 1999 Sep; 274(37):26033-43. PubMed ID: 10473550 [TBL] [Abstract][Full Text] [Related]
14. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Llovera M; Pichard C; Bernichtein S; Jeay S; Touraine P; Kelly PA; Goffin V Oncogene; 2000 Sep; 19(41):4695-705. PubMed ID: 11032019 [TBL] [Abstract][Full Text] [Related]
15. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms. Pellegrini I; Gunz G; Ronin C; Fenouillet E; Peyrat JP; Delori P; Jaquet P Endocrinology; 1988 Jun; 122(6):2667-74. PubMed ID: 3131120 [TBL] [Abstract][Full Text] [Related]
16. Glycosylated human prolactin: alterations in glycosylation pattern modify affinity for lactogen receptor and values in prolactin radioimmunoassay. Haro LS; Lee DW; Singh RN; Bee G; Markoff E; Lewis UJ J Clin Endocrinol Metab; 1990 Aug; 71(2):379-83. PubMed ID: 2380335 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of the receptor binding and Nb2 proliferation activities of rat prolactin by site-directed mutagenesis. Kato Y; Tomizawa K; Kato T Zoolog Sci; 1997 Feb; 14(1):147-52. PubMed ID: 9200987 [TBL] [Abstract][Full Text] [Related]
18. Structural characterization of the stem-stem dimerization interface between prolactin receptor chains complexed with the natural hormone. van Agthoven J; Zhang C; Tallet E; Raynal B; Hoos S; Baron B; England P; Goffin V; Broutin I J Mol Biol; 2010 Nov; 404(1):112-26. PubMed ID: 20875426 [TBL] [Abstract][Full Text] [Related]
19. A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor. Lorenson MY; Ueda EK; Chen KE; Walker AM Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E585-94. PubMed ID: 22205628 [TBL] [Abstract][Full Text] [Related]